Shenzhen New Industries Biomedical - Asset Resilience Ratio

Latest as of September 2025: 9.95%

Shenzhen New Industries Biomedical (300832) has an Asset Resilience Ratio of 9.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥953.21 Million

≈ $139.48 Million USD Cash + Short-term Investments

Total Assets

CN¥9.58 Billion

≈ $1.40 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Shenzhen New Industries Biomedical's Asset Resilience Ratio has changed over time. Check Shenzhen New Industries Biomedical PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen New Industries Biomedical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Shenzhen New Industries Biomedical.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥953.21 Million	9.95%
Total Liquid Assets	CN¥953.21 Million	9.95%

Asset Resilience Insights

Limited Liquidity: Shenzhen New Industries Biomedical maintains only 9.95% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen New Industries Biomedical Industry Peers by Asset Resilience Ratio

Compare Shenzhen New Industries Biomedical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Shenzhen New Industries Biomedical (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen New Industries Biomedical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.92%	CN¥1.72 Billion ≈ $252.20 Million	CN¥9.62 Billion ≈ $1.41 Billion	-10.74pp
2023-12-31	28.65%	CN¥2.36 Billion ≈ $344.75 Million	CN¥8.22 Billion ≈ $1.20 Billion	-11.46pp
2022-12-31	40.11%	CN¥2.81 Billion ≈ $411.73 Million	CN¥7.01 Billion ≈ $1.03 Billion	-5.63pp
2021-12-31	45.74%	CN¥2.81 Billion ≈ $410.68 Million	CN¥6.14 Billion ≈ $897.82 Million	+2.39pp
2020-12-31	43.35%	CN¥2.30 Billion ≈ $336.58 Million	CN¥5.31 Billion ≈ $776.39 Million	--

pp = percentage points

About Shenzhen New Industries Biomedical

SHE:300832 China Medical Devices

Market Cap

$5.50 Billion

CN¥37.61 Billion CNY

Market Cap Rank

#3322 Global

#435 in China

Share Price

CN¥47.87

Change (1 day)

-1.81%

52-Week Range

CN¥39.45 - CN¥70.18

All Time High

CN¥98.01